• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Imaging and Intervention

Many lung cancers visible on prior imaging studies

byDylan WolmanandAaron Maxwell, MD
September 26, 2014
in Imaging and Intervention, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Among patients with known lung cancer, evidence of malignancy was frequently present but undiagnosed on prior chest computed tomography (CT) scans obtained for the purposes of lung cancer screening.

2. In the present study, all malignant lung nodules that were visible on prior scans represented early, stage I tumors, while those that had appeared between screening exams tended to be more aggressive in stage and histology.

Evidence Rating Level: 3 (Average)

Study Rundown: Given the recent publication of guidelines recommending annual CT screening for lung cancer in adults with a significant smoking history, an evaluation of the diagnostic accuracy of screening CT and potential sources of error was undertaken by the International Early Lung Cancer Action Program. The present study compared chest CT images of patients with confirmed lung cancer to images from prior chest CT studies obtained during routine lung cancer screening with the goal of quantifying the rate at which cancers were previously visible but undiagnosed. Those lesions that were present on prior imaging but remained unidentified tended to be either of a similar size to pulmonary vascular markings or below the clinical detectability threshold of 3 mm in greatest dimension. Tumors not present on prior imaging represented the most aggressive cancers and were likely small, potentially below the resolving power of a standard screening CT scan. Superior identification of missed lesions may have been attained through the use of computer assisted segmentation for nodule detection and the use of maximum intensity projections in routine screening. Misclassification of lesions may have been prevented by publication of more thoroughly standardized features to distinguish suspicious lesions, underscoring a need for future systematic study. Limitations of the study included the use of expert consensus of three radiologists in determining the absence or presence of a lesion on prior examinations rather than a more objective method, the use of variable CT slice thickness parameters between patients, and a relatively small sample size given the broad and heterogeneous topic of population screening.

Click to read the study in the American Journal of Roentgenology

Relevant Reading: Lung cancer screening (JAMA)

In-Depth [retrospective cohort]: This multi-center study examined the CT scans of 104 patients with a diagnosis of lung cancer in whom a negative screening chest CT scan was available one year prior to a malignancy being identified. Three radiologists reviewed all prior negative studies to determine if a precursor lesion was present, and if so, if it was missed on initial reading or misinterpreted as a non-malignant nodule. No prior nodule was identified in 24 of 104 (23%) patients, and 71% of these patients were subsequently found to have stage I disease. Additionally, only 29% of these patients were diagnosed with adenocarcinoma versus 14% and 12% among patients with missed or misinterpreted lesions (p = 0.01), respectively. This group also contained the largest portion of small cell carcinomas at 29% (p = 0.12). All patients with a previously-identifiable lung nodule had stage I disease at the initial examination. Failure to report a nodule on the initial examination occurred in 56 of 104 (54%) patients, while the remaining 24 patients (23%) had lesions that were misinterpreted as non-malignant. The relative growth rate of nodules among patients with missed or misclassified lesions was significantly slower than those with negative initial exams (P < 0.0001) based on average nodule diameters.

RELATED REPORTS

Fleischner Society Guidelines, 2005 Statement: Limited CT follow-up recommended for small, solitary, pulmonary nodules [Classics Series]

Neoadjuvant nivolumab with chemotherapy increases survival in resectable non-small-cell lung cancer

#VisualAbstract: Segmentectomy is superior to lobectomy for patients with early-stage non-small cell lung cancer

More from this author: Intravenous contrast may not increase risk of acute kidney injury, Improved diagnosis of incidental adrenal masses by dual-energy CT, Image-guided biopsy of indeterminate ovarian masses appears safe and effective, Improved diagnosis of incidental adrenal masses by dual-energy CT

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

 

Tags: cancer screeninglung cancer
Previous Post

Adjuvant radiotherapy may improve survival in node-positive prostate cancer

Next Post

Mepolizumab reduces exacerbations in severe eosinophilic asthma [MENSA trial]

RelatedReports

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Radiology Classics

Fleischner Society Guidelines, 2005 Statement: Limited CT follow-up recommended for small, solitary, pulmonary nodules [Classics Series]

June 14, 2022
Surgical site anesthetic infusion may enhance analgesia after mastectomy
Oncology

Neoadjuvant nivolumab with chemotherapy increases survival in resectable non-small-cell lung cancer

May 30, 2022
#VisualAbstract: Increased physical activity is a long-term protective factor for dementia
StudyGraphics

#VisualAbstract: Segmentectomy is superior to lobectomy for patients with early-stage non-small cell lung cancer

May 18, 2022
Quick Take: Intravenous patient-controlled analgesia versus thoracic epidural analgesia after open liver surgery
Chronic Disease

Segmentectomy is superior to lobectomy for patients with early-stage non-small cell lung cancer

May 3, 2022
Next Post
Mepolizumab reduces exacerbations in severe eosinophilic asthma [MENSA trial]

Mepolizumab reduces exacerbations in severe eosinophilic asthma [MENSA trial]

Cryoablation safe and effective for pain control in sternal metastases

Cryoablation safe and effective for pain control in sternal metastases

Lower vulvar cancer-related mortality in African Americans

Subtype of metastatic esophageal cancer not a contraindication to surgery

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.